Tisagenlecleucel CAR-T for relapsed/refractory diffuse large B-cell lymphoma, one therapy; two different clinical presentations. An urgent need to design adverse event predictors
Jaromir Tomasik, J. Drozd-Sokołowska, P. Kacprzyk, A. Tomaszewska, R. Machowicz, E. Urbanowska, Samanta Witkowska, G. Basak
{"title":"Tisagenlecleucel CAR-T for relapsed/refractory diffuse large B-cell lymphoma, one therapy; two different clinical presentations. An urgent need to design adverse event predictors","authors":"Jaromir Tomasik, J. Drozd-Sokołowska, P. Kacprzyk, A. Tomaszewska, R. Machowicz, E. Urbanowska, Samanta Witkowska, G. Basak","doi":"10.5603/ahp.a2023.2018","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Haematologica Polonica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/ahp.a2023.2018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
